Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
mRNA-1273 Emergency use authorization Experimental Vaccine Apr/02/2021 18 0
BNT162b2 Emergency use authorization Experimental Vaccine Apr/02/2021 33 0
GC376 Potential treatment - pre-clinical evidence Experimental Antiviral Apr/01/2021 11 0
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/31/2021 40 44
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Mar/19/2021 81 18
Teicoplanin Potential treatment - pre-clinical evidence Experimental Antiviral Mar/06/2021 2 1
Suramin Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/05/2021 2 0
Mesenchymal stem cells Potential treatment - clinical evidence Experimental Other treatment Mar/05/2021 10 0
Azanitrile 8 Potential treatment - pre-clinical evidence Experimental Antiviral Mar/03/2021 1 0
Pyridyl ester 17 Potential treatment - pre-clinical evidence Experimental Antiviral Mar/03/2021 1 0